THI Medical Director Emerson C. Perin, MD, PhD, outlines Phase 3 Clinical Trial Results Demonstrate Promising Stem Cell Treatment Options...
- Labs & Centers
- Labs
- Cardiomyocyte Renewal Laboratory
- Cardiovascular Pathology Research
- Electrophysiology Basic Research
- Electrophysiology Clinical Research & Innovation
- Flow Cytometry & Imaging
- Gene Editing Lab
- Innovative Device & Engineering Applications Lab (IDEA
- Molecular Cardiology Research Laboratory
- Regenerative Medicine Research
- Centers
- Core Services
